Premium
Lyell Immunopharma Inc (LYEL)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-29 | Innovative Cellular Therapeutics Holdings LimitedSociété | -76,00k | 0,00 | Other Disposition | - | 2,86M | -2,59% |
| 2026-06-15 | Innovative Cellular Therapeutics Holdings LimitedSociété | -66,50k | 0,00 | Other Disposition | - | - | - |
| 2026-05-11 | Dr. Lynn SeelyPrincipal Executive Officer, President, CEO & Director | -388,00 | 7,34k | Vente | 18,91 | 73,88k | -0,52% |
| 2026-05-11 | Dr. Gary K. LeeChief Scientific Officer | -130,00 | 2,46k | Vente | 18,92 | 9,94k | -1,29% |
| 2026-05-11 | Mr. Stephen J. HillCOO | -89,00 | 1,68k | Vente | 18,92 | 10,03k | -0,88% |
| 2026-05-11 | Ms. Veronica Sanchez BulisVP, Corporate Controller, Principal Accounting Officer | -217,00 | 4,10k | Vente | 18,91 | 1,66k | -11,57% |
| 2026-06-10 | Dr. David R. ShookChief Medical Officer | -1,98k | 24,99k | Vente | 12,64 | 4,50k | -30,53% |
| 2026-03-06 | Arch Venture Partners, L.P.Société | 488,09k | 12,50M | Achat | 25,61 | 3,25M | 17,69% |
| 2026-02-11 | Dr. Lynn SeelyPrincipal Executive Officer, President, CEO & Director | -7,46k | 174,37k | Vente | 23,39 | 74,27k | -9,12% |
| 2026-02-11 | Mr. Stephen J. HillCOO | -1,24k | 28,91k | Vente | 23,39 | 17,80k | -6,49% |
| 2026-02-11 | Dr. Gary K. LeeChief Scientific Officer | -1,67k | 39,08k | Vente | 23,39 | 16,94k | -8,98% |
| 2026-02-10 | Mr. Stephen J. HillCOO | -109,00 | 2,52k | Vente | 23,12 | 10,81k | -1,00% |
| 2026-02-10 | Dr. Gary K. LeeChief Scientific Officer | -147,00 | 3,40k | Vente | 23,12 | 10,39k | -1,40% |
| 2026-02-10 | Dr. Lynn SeelyPrincipal Executive Officer, President, CEO & Director | -438,00 | 10,13k | Vente | 23,12 | 39,07k | -1,11% |
| 2026-02-10 | Ms. Veronica Sanchez BulisVP, Corporate Controller, Principal Accounting Officer | -254,00 | 5,87k | Vente | 23,12 | 1,29k | -16,43% |
| 2025-12-24 | Ms. Veronica Sanchez BulisVP, Corporate Controller, Principal Accounting Officer | -2,07k | 74,18k | Vente | 32,32 - 38,67 | 338,00 | -85,98% |
| 2025-11-10 | Dr. Lynn SeelyPrincipal Executive Officer, President, CEO & Director | -412,00 | 6,64k | Vente | 16,11 | 22,39k | -1,81% |
| 2025-11-10 | Ms. Veronica Sanchez BulisVP, Corporate Controller, Principal Accounting Officer | -239,00 | 3,85k | Vente | 16,10 | 2,41k | -9,02% |
| 2025-11-10 | Dr. Gary K. LeeChief Scientific Officer | -138,00 | 2,23k | Vente | 16,16 | 4,44k | -3,01% |
| 2025-11-10 | Mr. Stephen J. HillCOO | -95,00 | 1,53k | Vente | 16,12 | 4,83k | -1,93% |
| 2025-08-21 | Dr. Lynn SeelyPrincipal Executive Officer, President, CEO & Director | -7,26k | 76,52k | Vente | 10,54 | 22,81k | -24,14% |
| 2025-08-21 | Mr. Stephen J. HillCOO | -1,00k | 10,59k | Vente | 10,54 | 4,92k | -16,94% |
| 2025-08-21 | Mr. Charles W. NewtonInitié | -1,45k | 15,32k | Vente | 10,54 | 14,38k | -9,17% |
| 2025-08-21 | Dr. Gary K. LeeChief Scientific Officer | -1,45k | 15,32k | Vente | 10,54 | 4,58k | -24,08% |
| 2025-08-11 | Dr. Lynn SeelyPrincipal Executive Officer, President, CEO & Director | -797,00 | 8,31k | Vente | 10,34 - 10,53 | 10,06k | -7,34% |
| 2025-08-11 | Mr. Stephen J. HillCOO | -185,00 | 1,93k | Vente | 10,34 - 10,53 | 1,93k | -8,76% |
| 2025-08-11 | Dr. Gary K. LeeChief Scientific Officer | -267,00 | 2,78k | Vente | 10,34 - 10,53 | 2,04k | -11,60% |
| 2025-08-11 | Mr. Charles W. NewtonInitié | -267,00 | 2,78k | Vente | 10,34 - 10,53 | 11,84k | -2,21% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
